Table of Content

Analgesics in Peru
Euromonitor International
September 2021

List Of Contents And Tables

ANALGESICS IN PERU
KEY DATA FINDINGS
2021 DEVELOPMENTS
Analgesics continues to be helped by high levels of self-medication in 2021
Adult acetaminophen leads sales of analgesics
GSK Consumer Healthcare continues to lead in analgesics in 2021, benefiting from the wide recognition and good reputation of its Panadol brand
PROSPECTS AND OPPORTUNITIES
Demand for adult aspirin anticipated to drive sales of analgesics over the forecast period
Branded players will fight back against strengthening private label
Changes for generic analgesics expected into forecast period
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN PERU
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What’s next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources